The combined effect of metformin and mirabegron on diet‐induced obesity

Anti‐obesity medications act by suppressing energy intake (EI), promoting energy expenditure (EE), or both. Metformin (Met) and mirabegron (Mir) cause weight loss by targeting EI and EE, respectively. However, anti‐obesity effects during concurrent use of both have yet to be explored. In this study,...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Xin‐Yuan, Liu, Ying, Zhang, Xuan, Zhao, Ben‐Chi, Burley, George, Yang, Zhi‐Can, Luo, Yi, Li, An‐Qi, Zhang, Ruo‐Xin, Liu, Zhi‐Ying, Shi, Yan‐Chuan, Wang, Qiao‐Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9928947/
https://www.ncbi.nlm.nih.gov/pubmed/36818016
http://dx.doi.org/10.1002/mco2.207

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9928947/
https://www.ncbi.nlm.nih.gov/pubmed/36818016
http://dx.doi.org/10.1002/mco2.207

Ejemplares similares